Semax
Synthetic ACTH(4-10) heptapeptide studied in BDNF signaling, cognitive function, neurotransmitter modulation, and neuroprotection research.
$85.00
- FormatLyophilized Powder / 10 mg
- Storage-20°C for up to 24 months
Semax is a seven-amino-acid peptide originally developed by Russian researchers. Its structure includes a fragment derived from ACTH along with a short…
50 in stock
About Semax
Semax is a synthetic seven-amino-acid analog of ACTH(4-10). Preclinical research has examined Semax in relation to brain-derived neurotrophic factor (BDNF), neuronal survival, synaptic plasticity, serotonergic and dopaminergic signaling, cerebral ischemia, inflammatory pathways, and cognitive function. The supplied source also notes that the pharmaceutical formulation has been approved as a prescription nootropic in Russia; this research material is supplied for research use only.
Full Specification
| Molecular Formula | C37H51N9O10S |
| Molecular Weight | 813.93 g/mol |
| Purity | 99.08% |
| Appearance | White to off-white lyophilized powder |
| Storage | -20°C for up to 24 months |
| Format | Lyophilized Powder / 10 mg |
The Semax Molecule
An illustrative representation generated from the compound's molecular formula, alongside its logged molecular data. This figure is schematic — not a measured conformation.
How Semax Works
The pathways Semax acts on — and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
BDNF Modulation
Neurotrophic SignalingSemax has been studied in relation to BDNF expression, with levels up to 1.4-fold baseline measured in specific brain regions alongside neuronal survival and synaptic plasticity endpoints.
Serotonin & Dopamine Modulation
Neurotransmitter SignalingResearch has examined Semax in relation to serotonergic, dopaminergic, and noradrenergic systems involved in neurotransmitter signaling and cognitive processing.
Ischemic Models
NeuroprotectionSemax has been studied in cerebral ischemia models using infarct volume, inflammatory gene expression, neuronal survival, and oxidative-stress markers as research endpoints.
What Semax Is Researched For
Memory & Learning
Studied in animal models using cognitive function, memory consolidation, attention, and related behavioral endpoints.
Cerebral Ischemia Models
Studied in ischemic stroke models in relation to infarct volume, neuronal survival, inflammatory gene expression, and oxidative stress.
BDNF & Neurotrophin Signalling
Studied through BDNF and neurotrophin expression alongside neuronal plasticity and survival endpoints.
Immune Modulation
Studied in relation to pro-inflammatory cytokines and oxidative-stress-related gene expression in experimental models.
Study-Reported Magnitudes
Representative figures from published research; results vary by protocol.
Common Questions About Semax
Semax is a synthetic seven-amino-acid analog of ACTH(4-10) developed at a Russian research institute. Its sequence is Met-Glu-His-Phe-Pro-Gly-Pro.
Preclinical research has examined Semax in relation to BDNF expression, neuronal survival, synaptic plasticity, serotonin and dopamine signaling, cerebral ischemia, inflammatory pathways, and cognitive function.
The supplied source does not state that Semax is FDA approved. It states that the pharmaceutical formulation has been approved as a prescription nootropic in Russia since 2011. This material is supplied for research use only.
The supplied source does not provide a specific comparison between Semax and N-Acetyl Semax.
The supplied specification recommends storage at -20°C for up to 24 months.